Economics

This channel highlights factors that impact hospital and healthcare economics and revenue. This includes news on healthcare policies, reimbursement, marketing, business plans, mergers and acquisitions, supply chain, salaries, staffing, and the implementation of a cost-effective environment for patients and providers.

RSS icon
M&A mergers and acquisitions business deal

Boston Scientific to acquire Apollo Endosurgery for $615M

Under terms of the deal, Boston Scientific will pay $10 per share to acquire Apollo Endosurgery, well above the company’s previous day’s close of $6 per share.

healthcare value value-based care money dollar

FDA approves world’s most expensive drug, a hemophilia B treatment expected to cost $3.5M

The single-dose gene therapy can help patients reduce their risk of bleeding events and discontinue factor IX prophylaxis therapy.

Thumbnail

Health insurance woes: Americans ready to drop coverage if costs keep rising

The Biden-Harris administration helped expand access to health insurance coverage during the COVID-19 pandemic, but rising costs may still cause some Americans to drop insurance coverage altogether.

nursing_best_practices.png

Kaiser avoids historic nursing strike by boosting pay 22.5%

Kaiser Permanente staved off what would have been the largest private-sector nursing strike after reaching an agreement with 21,000 unionized Northern California nurses.

hearing aid

UnitedHealth, AARP team up for hearing aid savings

UnitedHealthcare has teamed up with AARP to administer hearing aid solutions, including prescription and over-the-counter (OTC) hearing aids.

Photo by <a href="https://unsplash.com/@clemono?utm_source=unsplash&utm_medium=referral&utm_content=creditCopyText">Clem Onojeghuo</a> on <a href="https://unsplash.com/s/photos/help-wanted?utm_source=unsplash&utm_medium=referral&utm_content=creditCopyText">Unsplash</a>

As recession looms, CEO turnover steadies

CEO turnover leveled out in October after a period marked by a high rate of departures in the healthcare industry.

Elon Musk and Eli Lilly: How a fake tweet caused chaos and reignited the debate over insulin prices

Updated Twitter policies have helped online pranksters cause mischief in recent days, including one specific user who impersonated Eli Lilly and Company and posted that insulin was now free. Lilly's CEO has now commented on the fake tweet read 'round the world—and what it could mean for the company going forward. 

Medicare money payment physician

Hospitals and health systems face ‘dire’ financial situations

Financial operations have turned dire for hospitals and health systems, according to a recent report that reviewed significant revenue losses and rising costs.

 

Displaying 401 - 408 of 2290

Around the web

Cardiovascular Business
Cardiologist compensation still rising, especially in invasive and interventional cardiology

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

Cardiovascular Business
FDA’s tirzepatide decision creates uncertainty for patients—and leads to a lawsuit

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Cardiovascular Business
Cardiology groups cheer new bill that would improve access to Medicare claims data

If passed, this bill would help clinician-led clinical registries explore Medicare data for research purposes. The Society of Thoracic Surgeons and American College of Cardiology both shared public support for the bipartisan legislation. 

Design by Adaptive Theme
Trimed Popup
Trimed Popup